Dermal Delivery Device with Reduced Loss of Its Volatile Components
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2008/069618, filed Jul 10, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,747,888 | Dermal Delivery Device with in Situ Seal In force · High confidence UsedRemaining | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 9,050,348 | Dermal Delivery Device In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 12,070,520 | Dermal Delivery Device In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 8,246,978 | Dermal Delivery Device with Reduced Loss of Its Volatile Components In force · High confidence | Agile Therapeutics, Inc., | In force | High confidence | ||
| US 9,775,817 | Transdermal Contraceptive Hormones Delivery In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 9,775,847 | Transdermal Contraceptive Hormones Delivery In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 9,775,848 | Transdermal Contraceptive Hormones Delivery In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 9,782,419 | Transdermal Contraceptive Hormones Delivery In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 9,192,614 | Contraceptive Transdermal Delivery of Hormones In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| US 9,198,876 | Contraceptive Transdermal Delivery of Hormones In force · High confidence | Agile Therapeutics, Inc. | In force | High confidence | ||
| 29 more records in this group · Pro | ||||||
10 of 39 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 39, including 5 expired.
13 of these are in force and held by Agile Therapeutics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.